U.S. stock index futures were slightly higher early Wednesday as traders digested the producer-price index which showed a measure of wholesale prices rose more than expected in September, while also awaiting the minutes from the Federal Reserve’s last policy meeting, due out later in the session, and a widely-followed consumer-price index report on Thursday.
How are stock-index futures trading
-
S&P 500 futures
ES00,
+0.27%
rose 11 points, or 0.3%, to 4,402 -
Dow Jones Industrial Average futures
YM00,
+0.29%
was up 85 points, or 0.3%, to 34,023 -
Nasdaq 100 futures
NQ00,
+0.34%
gained 58 points, or 0.4%, to 15,329
On Tuesday, the Dow Jones Industrial Average
DJIA
rose 135 points, or 0.4%, to 33,739, the S&P 500
SPX
increased 23 points, or 0.52%, to 4,358, and the Nasdaq Composite
COMP
gained 79 points, or 0.58%, to 13,563.
What’s driving markets
U.S. stock futures were little changed on Wednesday morning after the September producer-price index increased 0.5% for the month. That was down slightly from a 0.7% increase in August, but above the Dow Jones consensus of a 0.3% gain. The core PPI, which strips out food, energy and trade services components, rose 0.2% in September, in line with expectations.
See: Producer price inflation comes in a little hotter in September, highest annual rate in five months
The yield on the 10-year Treasury
BX:TMUBMUSD10Y
remained lower on Wednesday morning, off 6 basis points, at 4.599%, while the yield on the 2-year Treasury
BX:TMUBMUSD02Y
advanced 4 basis points, at 5.004%, according to FactSet data.
The decline in long-term implied borrowing costs comes after recent comments from Federal Reserve officials indicate the central bank may have finished raising interest rates for this cycle.
“Markets continued to grind higher as the headwinds of the Middle Eastern conflict were neutralized by a further softening of rhetoric from the Federal Reserve,” said Richard Hunter, head of markets at Interactive Investor.
‘’The surge of optimism, fueled by hopes the Fed will go easier with its interest rate policies…appears to have plateaued,” said Susannah Streeter, head of money and markets at Hargreaves Lansdown. “A little more caution is returning, as investors look ahead to tomorrow’s snapshot of inflation in the United States.”
The U.S. consumer price index report for September will be published before Thursday’s opening bell on Wall Street, but before that on Wednesday investors must also parse the minutes from the Fed’s previous policy meeting, due at 2 p.m.
“Investors are highly sensitive to data and if U.S. inflation shows any signs of tripping up in its downwards path, it is set to be unsettling and could upset expectations of a more dovish stance from the Fed,” Streeter added.
There’s another slew of Fed speakers on Wednesday, too. Fed Governor Christopher Waller will deliver comments in Park City, Utah at 10:15 a.m. Eastern, while Atlanta Fed President Raphael Bostic is due to speak on the economic outlook at 12:15 p.m., and Boston Fed President Susan Collins gives the Goldman Lecture on Economics at Wellesley College at 4:30 p.m..
Traders were also awaiting the start of the third-quarter company earnings season, which gets in full swing when banks such as JPMorgan Chase
JPM,
Citigroup
C,
and Wells Fargo
WFC,
deliver their numbers on Friday.
Companies in focus
-
Exxon Mobil
XOM,
-0.42%
dropped 2.2% on Wednesday morning after the company reached an agreement to purchase shale-drilling company Pioneer Natural Resources
PXD,
+0.76%
for $59.5 billion in stock. Shares of Pioneer Natural Resources rose 2% in premarket trading. -
DaVita Inc.
DVA,
+3.14% ,
a dialysis-services provider, plunged 16.2% and the U.S.-listed shares of Fresenius Medical Care
FMS,
+0.92%
declined 15.7% after the trial success of Novo Nordisk’s hit drug against kidney failure sent shares of kidney dialysis services firms plummeting.
Read the full article here